Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in

Christos Haritoglou1, Marcus Kernt, Aljoscha Neubauer

  • 1*Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany; †Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany; and ‡Critical Health SA, Coimbra, Portugal.

Abstract

Insights

Automated analysis of microaneurysm (MA) formation rate can predict clinically significant macular edema (CSME) in diabetic retinopathy patients. A rate of 2 or more new MAs identifies high-risk individuals, aiding personalized screening for diabetic eye disease.

Area of Science:

  • Ophthalmology
  • Diabetic Retinopathy Research
  • Medical Imaging Analysis

Background:

  • Diabetic retinopathy (DR) is a leading cause of vision loss.
  • Clinically significant macular edema (CSME) is a major complication of DR.
  • Early detection and risk stratification are crucial for managing DR.

Purpose of the Study:

  • To assess the predictive capability of microaneurysm (MA) formation rate for CSME development.
  • To evaluate an automated fundus photograph analysis for this prediction.
  • To correlate MA formation rate with CSME in mild-to-moderate nonproliferative diabetic retinopathy.

Main Methods:

  • Retrospective analysis of 287 eyes with mild-to-moderate nonproliferative diabetic retinopathy.
  • Automated analysis of central field fundus photographs (30°) using RetmarkerDR software.
  • Calculation of MA formation rate over 12 months and prediction of CSME development up to 5 years.

Main Results:

  • An MA formation rate of ≥2 MAs was significantly associated with CSME development.
  • The automated analysis achieved 70.2% sensitivity and 71.7% specificity in predicting CSME.
  • Positive predictive value was 33%, and negative predictive value was 92.5%.

Conclusions:

  • Automated MA formation rate analysis using RetmarkerDR software can identify patients at higher risk for CSME.
  • The high negative predictive value supports its use in risk stratification.
  • This tool may enable personalized screening intervals for diabetic retinopathy complications.